| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Sep 5, 2024
State-of-the-art facility based in Singapore aims to accelerate adoption of Robotics and AI across Southeast Asia through training and education, improving access to new healthcare technologies and delivering better care experiences across the region
-
Sep 4, 2024
The company will present clinical evidence in young children, pregnancy and type 2 diabetes*
-
Aug 22, 2024
Post-market data collection will add real-world experience to established safety, efficacy, and efficiency evidence profile
-
Aug 21, 2024
New MRI labeling extends active scan time for Medtronic DBS systems
-
Aug 12, 2024
First ever FDA approval provides more options to meet patients’ personalized needs, including those with Parkinson’s disease
-
Jun 20, 2024
Deal expands Pain Interventions portfolio, now offering both unipedicular and bipedicular vertebral augmentation solutions
-
Jun 7, 2024
New York Valves 2024: Late-breaking data included a SMART Trial secondary analysis showing significantly less bioprosthetic valve dysfunction with Evolut TAV across the entire range of small annulus areas when compared with the Edwards Sapien 3™ TAV platform, and CoreValve-Evolut pooled analysis demonstrating valve performance and durability benefits versus surgery.


